Articles worth reading
No Stone Unturned film to be shown at An Táin Arts Centre this Thursday

No Stone Unturned film to be shown at An Táin Arts Centre this Thursday

access_time 4 weeks ago

There will be a screening of the film ‘No Stone Unturned’ at An Táin Arts Centre on Thursday evening at

More than 450 safety lapses at Sellafield since 2001

More than 450 safety lapses at Sellafield since 2001

access_time 1 year ago

More than 450 safety lapses have occurred at the Sellafield nuclear power plant since 2001. That’s according to a new

Big Mountain Productions enter into partnership with American network PBS

access_time 5 years ago

Dundalk-based company Big Mountain Productions has entered into a partnership with American network PBS which will involve the US version

Dundalk as it Happens

Nova Leah announces acquisition of Fresenius Medical Care as a customer

Nova Leah announces acquisition of Fresenius Medical Care as a customer

access_time 9 months ago
shareShare this post

Nova Leah, the Dundalk headquartered medical device security company, has announced a significant global customer win.

Fresenius Medical Care, a provider of dialysis products and services, which reported revenues of US$17.9bn in 2016, has selected and will implement Nova Leah’s cybersecurity risk management tool Select Evidence.

Select Evidence is the world’s first expert cybersecurity risk management system for connected medical devices.

Nova Leah recently announced the creation of 78 jobs in Dundalk. It is initially targeting customers in the imaging and electro medical device sectors in the US, a market that is estimated to be worth $155bn of which connected devices account for approximately $51bn.

Fresenius Medical Care meanwhile employs over 100,000 people worldwide and cares for more than 300,000 patients in its global network of over 3,600 dialysis clinics.

According to a report in The Irish Independent, the German company operates over 30 production sites worldwide to provide products such as dialysis machines and dialyzers.

SelectEvidence is designed to guide medical device manufacturers implementing cybersecurity requirements and best practices over the lifetime of devices in compliance with US FDA (Food & Drug Administration) recommendations during premarket and post market activities.

shareShare this post
folder_openAssigned tags
content_copyCategorized under